ArticleAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2026
Evolution of out-of-sequence liver allocation, 2019-2024.
Article in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Allocation out-of-sequence (AOOS) refers to deviation from the match run order in deceased donor organ allocation and is intended for use in exceptional cases to expedite organ placement. Contemporary patterns of AOOS in liver transplantation are not well characterized. This study aimed to describe liver AOOS practices and examine their association with organ utilization. Liver match runs from 2019 to 2024 were analyzed using the Organ Procurement and Transplantation Network potential transplant recipient data set to identify AOOS events. Data from the Scientific Registry of Transplant Recipients were incorporated to analyze program- and Organ Procurement Organization (OPO)-specific organ utilization and offer acceptance. AOOS prevalence, timing, and geographic variability were examined, and correlations with adjusted utilization metrics were assessed. AOOS increased from 5% in 2019 to 18% in 2024, with use concentrated in a subset of OPOs (range, 2%-39%; median, 17%) and centers (range, 0%-55%; median, 10%), often in shared geographic areas. From 2019 to 2024, AOOS offers were initiated progressively earlier in the allocation process. OPO-level AOOS use was not correlated with donor yield, though center-level AOOS acceptance was associated with higher adjusted offer acceptance. These findings highlight a potential need for further standardization of AOOS practices in liver transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.